# Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Bone Sites

> **NCT02436876** · PHASE2 · COMPLETED · sponsor: **Microbion Corporation** · enrollment: 29 (actual)

## Conditions studied

- Bacterial Infection

## Interventions

- **DRUG:** MBN-101
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02436876
- **Lead sponsor:** Microbion Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-24
- **Primary completion:** 2017-10-27
- **Final completion:** 2018-07-26
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2021-09-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02436876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02436876, "Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Bone Sites". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02436876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*